Audits done? Box checked? Think again. Treating supplier quality oversight as a one-and-done compliance exercise is not just outdated. In a world where conflicts, tariffs, regulatory changes and climate disruptions are daily headlines – it´s a dangerous illusion.
This whitepaper is a wake-up call for pharma, biotech, and medtech leaders. Written by Dr. Marco Retzlaff, a seasoned quality expert, this whitepaper draws on insights from top pharma leaders, regulatory bodies and real-world industry cases to expose the hidden risks in traditional supplier quality oversight approaches — and offer a blueprint for change.
Download the full article to:
- Shift Quality from the ‘backroom’ to the ‘boardroom’
- Avoid revenue loss and patient costs caused by poor oversight
- See what ‘good’ quality practice looks like
- Lead the shift
👉 Get your free copy of the white paper. Fill out the form to access it instantly.
